The TIMER and GEPIA datasets revealed that the expression of TBC1D1 was higher in HCC than in normal tissues, and the UALCN dataset showed that TBC1D1 expression was also correlated with the clinical characteristics of patients with HCC. Here, TBC1D1 is linked to hepatocellular carcinoma.